ViQi
ViQi empowers scientists to accelerate discoveries, reduce costs, and make advanced therapies more accessible through AI-powered image solutions and custom assays. The company specializes in creating seamless, regulatory-compliant solutions that integrate into existing workflows, helping clients bring innovations to market faster and more efficiently. With a focus on bioassays, digital pathology, and spatial biology, ViQi collaborates with industry leaders and academic institutions to develop cutting-edge AI-driven platforms that enhance research and drug development processes.
Industries
Nr. of Employees
small (1-50)
Patents
Efficient multi-dimensional storage of very large dense, sparse and semi-sparse image datasets with machine learning
US-12536608-B2
View Details
Efficient multi-dimensional storage of very large dense, sparse and semi-sparse image datasets with machine learning
US-12536608-B2
View DetailsProducts
AI-based infectivity assay (brightfield ML)
Automated image-analysis assay that uses machine learning on brightfield images to detect viral infection phenotypes rapidly without fluorescent staining.
Adaptive high-content screening toolkit (image analysis service)
Service/toolkit that converts high-content images into phenotypic clusters, time-course analyses, and mechanism-of-action insights using lab-specific AI models and bioinformatics visualizations.
Digital pathology fibrosis quantification and spatial analysis
Quantitative histology solution for detecting fibrosis, single-fiber features, cell phenotyping, tumor detection and spatial phenotyping across whole slides with support for brightfield and multiplex fluorescence.
Automated Viral Infectivity Assay
AVIA is an AI-based assay that uses machine learning and brightfield microscopy to detect phenotypic changes associated with viral infection before they are visible to the human eye, replacing traditional plaque assays and TCID50s.
AVIA Automated Viral Infectivity Assay
AVIA is an AI-based assay that uses machine learning and brightfield microscopy to detect phenotypic changes associated with viral infection prior to visible CPEs without requiring intensive genetic engineering or fluorescent labeling.
AutoHCS
AutoHCS is an adaptable, AI-powered image analysis system designed for cellular or tissue-based high-content screening assays, customizing its analysis to meet specific experimental needs and automatically detecting and scoring phenotypic responses.
AI-based infectivity assay (brightfield ML)
Automated image-analysis assay that uses machine learning on brightfield images to detect viral infection phenotypes rapidly without fluorescent staining.
Adaptive high-content screening toolkit (image analysis service)
Service/toolkit that converts high-content images into phenotypic clusters, time-course analyses, and mechanism-of-action insights using lab-specific AI models and bioinformatics visualizations.
Digital pathology fibrosis quantification and spatial analysis
Quantitative histology solution for detecting fibrosis, single-fiber features, cell phenotyping, tumor detection and spatial phenotyping across whole slides with support for brightfield and multiplex fluorescence.
Automated Viral Infectivity Assay
AVIA is an AI-based assay that uses machine learning and brightfield microscopy to detect phenotypic changes associated with viral infection before they are visible to the human eye, replacing traditional plaque assays and TCID50s.
AVIA Automated Viral Infectivity Assay
AVIA is an AI-based assay that uses machine learning and brightfield microscopy to detect phenotypic changes associated with viral infection prior to visible CPEs without requiring intensive genetic engineering or fluorescent labeling.
AutoHCS
AutoHCS is an adaptable, AI-powered image analysis system designed for cellular or tissue-based high-content screening assays, customizing its analysis to meet specific experimental needs and automatically detecting and scoring phenotypic responses.
Services
Design and deliver custom image-based assays and AI models aligned to client experimental protocols and validation requirements.
AI-driven infectivity testing using brightfield imaging to detect infection-related phenotypes rapidly without fluorescent staining; supports high-throughput workflows and BSL3/BSL4 contexts.
Image-based high-content screening analysis service that trains lab-specific AI models to detect phenotypes, perform time-course studies, and cluster compound responses for mechanism insights.
High-throughput slide analysis including fibrosis quantification, single-fiber detection, cell phenotyping, and spatial biology analyses for preclinical and translational research.
Technical support for imager configuration, secure data transfer to cloud, and workflow integration with client IT teams.
Subscription access to the cloud platform for ongoing use of assays, access to historical data, and data provenance management under client-specified retention policies.
Design and deliver custom image-based assays and AI models aligned to client experimental protocols and validation requirements.
AI-driven infectivity testing using brightfield imaging to detect infection-related phenotypes rapidly without fluorescent staining; supports high-throughput workflows and BSL3/BSL4 contexts.
Image-based high-content screening analysis service that trains lab-specific AI models to detect phenotypes, perform time-course studies, and cluster compound responses for mechanism insights.
High-throughput slide analysis including fibrosis quantification, single-fiber detection, cell phenotyping, and spatial biology analyses for preclinical and translational research.
Technical support for imager configuration, secure data transfer to cloud, and workflow integration with client IT teams.
Subscription access to the cloud platform for ongoing use of assays, access to historical data, and data provenance management under client-specified retention policies.
Expertise Areas
- AI-driven image analysis for life sciences
- High-content screening and phenotypic screening
- Viral infectivity assay development
- Digital pathology and spatial biology
Key Technologies
- Machine learning for image analysis
- Brightfield and phase-contrast microscopy image processing
- Automated plate imaging (96-well) integration
- SaaS cloud infrastructure (AWS)
News & Updates
ViQi Demonstrates Viral Infectivity Assay Using AI and Brightfield Imaging
ViQi showcased a high throughput cell imager and AI-based image analysis platform for assessing infectivity of various viruses in a 96-well plate, in partnership with North Carolina State University, Baylor College of Medicine, and others.
FibroNest AI Solution for Digital Pathology
FibroNest, developed in partnership with PharmaNest, is an AI solution for phenotypic quantification of fibrosis, used in over 150 preclinical and clinical trials, including a Phase 3 trial with Galmed's Aramchol.
Partnership with Akoya Biosciences for Spatial Biology
ViQi and Akoya Biosciences collaborate to enable spatial phenotyping of cells across whole slides, reducing pipeline processing time from weeks to days.
Science that Saves Lives
ViQi's technology empowers scientists to uncover insights faster, reducing costs and improving access to advanced therapies through custom assays and AI solutions.
Custom Assays Guided by Scientists–Powered by AI
ViQi develops customized, AI-powered assays tailored to specific scientific needs, supporting regulatory compliance and operational efficiency.
Partnering for Innovation in Tissue Analysis and Fibrosis Research
ViQi's platform supports rapid assay development, high-throughput analysis, and industry-leading accuracy in tissue and fibrosis analysis, with collaborations across industry and academia.
ViQi Demonstrates Viral Infectivity Assay Using AI and Brightfield Imaging
ViQi showcased a high throughput cell imager and AI-based image analysis platform for assessing infectivity of various viruses in a 96-well plate, in partnership with North Carolina State University, Baylor College of Medicine, and others.
FibroNest AI Solution for Digital Pathology
FibroNest, developed in partnership with PharmaNest, is an AI solution for phenotypic quantification of fibrosis, used in over 150 preclinical and clinical trials, including a Phase 3 trial with Galmed's Aramchol.
Partnership with Akoya Biosciences for Spatial Biology
ViQi and Akoya Biosciences collaborate to enable spatial phenotyping of cells across whole slides, reducing pipeline processing time from weeks to days.
Science that Saves Lives
ViQi's technology empowers scientists to uncover insights faster, reducing costs and improving access to advanced therapies through custom assays and AI solutions.
Custom Assays Guided by Scientists–Powered by AI
ViQi develops customized, AI-powered assays tailored to specific scientific needs, supporting regulatory compliance and operational efficiency.
Partnering for Innovation in Tissue Analysis and Fibrosis Research
ViQi's platform supports rapid assay development, high-throughput analysis, and industry-leading accuracy in tissue and fibrosis analysis, with collaborations across industry and academia.